• 101 引文
  • 6 h-指數
20142019

Research output per year

如果您對這些純文本內容做了任何改變,很快就會看到。

研究成果

  • 101 引文
  • 6 h-指數
  • 20 Article
篩選
Article
2019
開啟存取
開啟存取
2018
4 引文 斯高帕斯(Scopus)

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

Hsu, J. C., Lin, J. Y., Hsu, M. Y. & Lin, P. C., 2018 八月, 於 : PloS one. 13, 8, e0202725.

研究成果: Article

1 引文 斯高帕斯(Scopus)

Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-Glucose Co-Transporter-2 Inhibitors on Oral Antidiabetic Drug Utilization

Chen, H. Y., Chiu, P. Y., Chang, C. J., Tsai, L. L., Huang, Y. L. & Hsu, J. C., 2018 十二月 1, 於 : Clinical Drug Investigation. 38, 12, p. 1125-1133 9 p.

研究成果: Article

1 引文 斯高帕斯(Scopus)

Use of assisted reproductive technologies before and after the Artificial Reproduction Act in Taiwan

Hsu, J. C., Su, Y. C., Tang, B. Y. & Lu, C. Y., 2018 十一月, 於 : PloS one. 13, 11, e0206208.

研究成果: Article

2017
12 引文 斯高帕斯(Scopus)
2 引文 斯高帕斯(Scopus)
11 引文 斯高帕斯(Scopus)
2016
6 引文 斯高帕斯(Scopus)

Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in Taiwan

Hsu, J. C., Gonzalez-Gonzalez, L. A., Lu, V. H. & Lu, C. Y., 2016 五月 27, 於 : BMJ open. 6, 5, p. e010706

研究成果: Article

2 引文 斯高帕斯(Scopus)
2015

Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan

Hsu, J. C., Cheng, C. L., Ross-Degnan, D., Wagner, A. K., Zhang, F., Kao Yang, Y. H., Liu, L. L., Tai, H. Y., Chen, K. H., Yang, P. W. & Lu, C. Y., 2015 十月 1, 於 : Pharmacoepidemiology and drug safety. 24, 10, p. 1026-1035 10 p.

研究成果: Article

4 引文 斯高帕斯(Scopus)

How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?

Hsu, J. C., Ross-Degnan, D., Wagner, A. K., Zhang, F. & Lu, C. Y., 2015 七月 21, 於 : Clinical Therapeutics. 37, 7, p. 1420-1432.e1

研究成果: Article

7 引文 斯高帕斯(Scopus)

Net clinical benefit of oral anticoagulants: A multiple criteria decision analysis

Hsu, J. C., Hsieh, C. Y., Yang, Y. H. K. & Lu, C. Y., 2015 四月 21, 於 : PloS one. 10, 4, e0124806.

研究成果: Article

13 引文 斯高帕斯(Scopus)
5 引文 斯高帕斯(Scopus)
10 引文 斯高帕斯(Scopus)
6 引文 斯高帕斯(Scopus)
2014

Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: An interrupted time series study

Hsu, J. C., Lu, C. Y., Wagner, A. K., Chan, K. A., Lai, M. S. & Ross-Degnan, D., 2014 六月, 於 : Health Policy. 116, 2-3, p. 196-205 10 p.

研究成果: Article

11 引文 斯高帕斯(Scopus)
6 引文 斯高帕斯(Scopus)